Test Code HEPATITIS B CORE ANTIBODY IgM HEPATITIS B CORE ANTIBODY IgM
Department
Immunology
Specimen Type
Serum
Method
Chemiluminescent Microparticle Assay
Container
No additive with gel (gold top)
Special Requirements
Centrifuge sample within 24 hours post draw.
Standard Volume
4.5ml
Minimum Volume
3ml
Pediatric Volume
1.6ml
Ship Temperature
Refrigerated
Stability Refrigerated
7 days
Stability Room Temp
72 hours
Stability Frozen
>7 days
CPT Code
86705
Days Test Set Up
Monday through Friday
Group Components
HEPATITIS B CORE ANTIBODY, IGM
Clinical Information
Hepatitis B virus (HBV) is endenic throughout the world and is the major cause of liver disease. HBV is transmitted through the direct contact with blood and body fluids. Common modes of transmission include blood transfusion, needle puncture, direct contact with open wounds, sexual contact, and mother-neonate contact during birth. The average incubation for HBV infections is 6 to 8 weeks. Infections is usually asymptomatic. Common clincal symptoms include malaise, fever, gastroenteritis, and icterus. HBV infection can result in typical icteric hepatitis, subclinical anti-icteric hepatitis, fulminant hepatitis, or chronic hepatitis. Anti-HB core IgM titers increase rapidly, peak during the acute infection state of HBV infection, and then fall to a relatively low level as the patient recovers or becomes a chronic carrier. Anti-HBc IgM may be the only specific marker for the diagnosis of acute HBV infection.
Test Use
For the qualitative determination of IgM response to hepatitis B virus core antigen. This assay may be used in combination with other hepatitis B virus marker assays to define the clinical status of known HBV infected patients or cam be combined with other HBV, HAV, and HCV assays for the diagnosis of patients presenting symptoms of acute viral hepatitis.
Cautions
The performance of the assay has not be established for populations of immunocompromised or immunosupressed patients, cord blood, neonatal specimens, cadaver specimens, or body bluids.
A reactive anti-HB core IgM result does not exclude co-infection by another hepatitis virus.
Interpretation
Negative are considered nonreactive for IgM antibodies to hepatitis B core antigen.
Positive are considerede reactive for IgM antibodies to hepatitis B core antigen.